Institutional Ownership Arrowhead Pharmaceuticals, Inc. (ARWR)
This table provides information about the institutional ownership of Arrowhead Pharmaceuticals, Inc. (ARWR). We have compiled data on the 296 institutions that hold shares in the stock, with a total of 88.5 Million shares, which have been reported (via 13F filing form) to have a value of $2.3 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Black Rock Inc.
New York, NY |
May 10, 2024 Q1 2024 |
15,346,637
shares
|
$399 Million
0.01% of portfolio
|
Q1 2024
Added 15.36%
|
|
Vanguard Group Inc
Valley Forge, PA |
May 10, 2024 Q1 2024 |
12,404,050
shares
|
$322 Million
0.01% of portfolio
|
Q1 2024
Added 16.23%
|
|
Avoro Capital Advisors LLC
New York, NY |
May 15, 2024 Q1 2024 |
8,555,555
shares
|
$222 Million
2.95% of portfolio
|
Q1 2024
Added 657.13%
|
|
State Street Corp
Boston, MA |
May 15, 2024 Q1 2024 |
6,560,703
shares
|
$171 Million
0.01% of portfolio
|
Q1 2024
Reduced 3.87%
|
|
Slate Path Capital LP
New York, NY |
May 15, 2024 Q1 2024 |
4,139,000
shares
|
$108 Million
2.38% of portfolio
|
Q1 2024
Added 211.44%
|
|
Artal Group S.A.
Luxembourg, N4 |
May 17, 2024 Q1 2024 |
3,036,668
shares
|
$78.9 Million
4.68% of portfolio
|
Q1 2024
Added 195.32%
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2024 Q1 2024 |
2,754,634
shares
|
$71.6 Million
0.01% of portfolio
|
Q1 2024
Added 18.38%
|
|
Jpmorgan Chase & CO
New York, NY |
May 10, 2024 Q1 2024 |
2,638,063
shares
|
$68.6 Million
0.01% of portfolio
|
Q1 2024
Reduced 4.11%
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
May 15, 2024 Q1 2024 |
1,758,883
shares
|
$45.7 Million
0.03% of portfolio
|
Q1 2024
New holding
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
1,626,513
shares
|
$42.3 Million
0.05% of portfolio
|
Q1 2024
Reduced 6.81%
|
|
Northern Trust Corp
Chicago, IL |
May 14, 2024 Q1 2024 |
1,300,649
shares
|
$33.8 Million
0.01% of portfolio
|
Q1 2024
Added 5.78%
|
|
Rokos Capital Management LLP
London, X0 |
May 17, 2024 Q1 2024 |
1,229,148
shares
|
$31.9 Million
0.19% of portfolio
|
Q4 2023
Reduced 26.66%
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
May 14, 2024 Q1 2024 |
1,225,987
shares
|
$31.9 Million
0.04% of portfolio
|
Q1 2024
Added 10418.08%
|
|
Morgan Stanley
New York, NY |
May 15, 2024 Q1 2024 |
1,135,867
shares
|
$29.5 Million
0.0% of portfolio
|
Q1 2024
Added 26.28%
|
|
Goldman Sachs Group Inc
New York, NY |
May 15, 2024 Q1 2024 |
1,049,539
shares
|
$27.3 Million
0.01% of portfolio
|
Q1 2024
Reduced 1.17%
|
|
Ameriprise Financial Inc
Minneapolis, MN |
May 15, 2024 Q1 2024 |
997,297
shares
|
$25.9 Million
0.01% of portfolio
|
Q1 2024
Added 7.4%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 08, 2024 Q1 2024 |
983,755
shares
|
$25.6 Million
0.01% of portfolio
|
Q1 2024
Added 16.29%
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
May 15, 2024 Q1 2024 |
933,900
shares
|
$24.3 Million
0.01% of portfolio
|
Q1 2024
Reduced 1.83%
|
|
Aquilo Capital Management, LLC
San Francisco, CA |
May 15, 2024 Q1 2024 |
908,474
shares
|
$23.6 Million
20.27% of portfolio
|
Q3 2023
Added 5.82%
|
|
Western Financial Corporation
|
Nov 03, 2022 Q3 2022 |
820,320
shares
|
$21.3 Million
18.96% of portfolio
|
Q2 2022
Added 0.0%
|
|
Western Financial Corp/Ca
San Diego, CA |
Apr 24, 2024 Q1 2024 |
820,239
shares
|
$21.3 Million
14.38% of portfolio
|
Q3 2023
Reduced 0.01%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2024 Q1 2024 |
741,897
shares
|
$19.3 Million
0.0% of portfolio
|
Q1 2024
Added 1165.24%
|
|
Orbimed Advisors LLC
San Diego, CA |
May 15, 2024 Q1 2024 |
739,651
shares
|
$19.2 Million
0.48% of portfolio
|
Q1 2024
Added 131.39%
|
|
E. Ohman J:Or Asset Management Ab
Stockholm, V7 |
May 14, 2024 Q1 2024 |
640,160
shares
|
$16.6 Million
0.47% of portfolio
|
Q1 2024
Reduced 0.27%
|
|
Woodline Partners LP
San Francisco, CA |
May 15, 2024 Q1 2024 |
555,628
shares
|
$14.4 Million
0.15% of portfolio
|
Q1 2024
Reduced 40.07%
|